Mice were treated with 100 mg/kg Rb (1-b-D-ribofuranosyl-1,2,4-triazole-3-carboxamide, Virazole; ICN Pharmaceuticals, Costa Mesa, CA, USA) in PBS. We observed no toxicity with the use of Rb. Treatment was administered once daily intraperitoneally (i.p.) on days 1–8 after LCMV infection. Control mice were injected in parallel with PBS (vehicle-only control).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.